Integrated Cas12a and Cas13a CRISPR platform enables multifunctional nucleic acid detection for tumor screening and viral diagnostics
By
Zhou, Jingcong, Liu, Wenzheng, Nie, Xiaoqi, Wang, Xiaoxiang, Hu, Yibo, Wan, Changqing, Liao, Yangwei, Pan, Shutao
Toasted golden, schmeared with insight. Top of the rack.
Summary
This article describes the development of a multifunctional nucleic acid response platform that integrates the Cas12a and Cas13a CRISPR/Cas systems for enhanced biodetection. The research addresses the limited compatibility of CRISPR/Cas-based signaling systems with diverse input types by creating an integrated targeting system that overcomes the restricted activation mechanisms of Cas proteins. The platform is designed for applications in early tumor screening, viral detection, and molecular logic circuits, leveraging the simplicity and efficiency of CRISPR technology.
Key quotes
· 3 pulledSince its discovery, the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas system has ushered in a transformative era in biodetection, leveraging its simplicity and efficiency to enable Cas protein-based signaling systems for applications in early tumor screening, viral detection, and molecular logic circuits.
However, the constrained compatibility of CRISPR/Cas-based signaling systems with diverse input types limits their versatility, primarily due to the restricted activation mechanisms of the Cas protein.
Herein, we developed the Cas12...
You might also wanna read

New CRISPR Technique Selectively Destroys Cancer Cells with Common Mutation
Researchers at UC Berkeley, UCSF, and Gladstone Institutes have developed a novel CRISPR-based technique called "RNA-Triggered Chromatin Shr
innovativegenomics.org·22h agoScientists Engineer Proteins to Act as Qubits for Cellular Disease Monitoring
Scientists are exploring the intersection of quantum computing and biology by genetically engineering proteins to function like qubits. This

CRISPR-Engineered Fat Cells Show Promise for Starving Cancer Tumors
Researchers at UC San Francisco have developed a novel cancer treatment approach using CRISPR-engineered fat cells to starve tumors. They tr
CRISPR takes a bold leap toward silencing Down syndrome's extra chromosome
Gemma-Based AI Model Identifies Potential Cancer Therapy Pathway Through Conditional Immune Amplification
Researchers used a new 27 billion parameter foundation model called C2S-Scale 27B, built on Google's Gemma family of open models, to discove

AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t

AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t
